ESPL1 and hepatocellular carcinoma: There is growing evidence that high expression of ESPL1 is strongly associated with the development of malignant tumours, such as hepatocellular carcinoma (HCC) [11], glioma [12], lung adenocarcinoma (LUAD) [13] and colorectal cancer (CRC) [14].